“While completing an internship as a naval officer in the medical department, I saw a high number of foot infections in military personnel. I wanted to find a way to prevent and treat these fungal and bacterial infections and those conditions associated,” Dr Punyawee Ongsri (Siriraj Piyamaharajkarun Hospital, Mahidol University, Thailand) explained the motivation for the presented study [1].
Metal oxides have shown antibacterial action for a wide range of bacteria, including antibiotic-resistant species. They act by generating reactive oxygen species that may destroy bacterial walls and, for example, induce bacterial DNA damage. “Antibacterial efficacy is determined by size and concentration of the particles,” stated Dr Ongsri. Previous studies have shown that several metal oxide particles like zinc, titanium, silver, or silica can have antibacterial effects and some are already used in different industrial fields. Special features of zinc oxide nanoparticles (ZnO-NP) are their photocatalyticity and the lack of evidence of environmental toxicity in contrast to, for example, silver oxide.
The double-blind, randomised controlled trial included more than 140 cadets of the Thai Naval Rating School, who took part in a 2-week field training course and had no history of bromodosis or abnormal foot lesions like pitted keratolysis. The cadets were provided with 2 pairs of either ZnO-NP-coated socks or uncoated socks. The groups were not statistically different in baseline characteristics.
Before the training, a self-assessment of foot odour and a dermatologic, intervention-blinded examination was performed along with the completion of a questionnaire on behavioural risk factors by the cadets. During training, the provided socks had to be worn ≥8 hours a day and the use of any foot treatment such as deodorant was not allowed. After the training, the same assessments followed.
The results showed significantly less cases of pitted keratolysis (15.7% vs 40.5%; P=0.05) and a reduction in foot odour (-0.34 vs -0.14; P=0.34; see Table). The ZnO-NP-coated socks were also associated with high satisfaction in use by the cadets compared with the uncoated socks (95.9% vs 83.8%; P=0.01). “Persons in the uncoated-sock group complained of a more intense foot odour, which had a moderate to large effect on their daily life,” stated Dr Ongsri. He concluded: “We propose that wearing these socks could be adopted as a primary prevention in populations at risk, especially in military personal.”
Table: Results after the 2-week field training course [1]
*Mann-Whitney U test; **unpaired t-test.
ZnO-NP, zinc oxide nanoparticles; VAS, visual analogue scale.
- Ongsri P, et al. Effectiveness and safety of zinc oxide nanoparticle-coated socks compared to uncoated socks for the prevention of unpleasant foot odour: A double-blinded, randomized, controlled trial study. FC05.05, EADV 2020 Virtual Congress, 29-31 Oct.
- Dizaj SM, et al. Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84.
- Fiedot-Toboła M, et al. Materials (Basel). 2018;11:707.
- Padmavathy N, Vijayaraghavan R. Sci Technol Adv Mater. 2008;9:035004.
- Gao J, et al. 2015;119:948-52.
Posted on
Previous Article
« Baricitinib in AD: Efficacy paired with consistent long-term results Next Article
Meaningful sleep improvement with IL-13 inhibition »
« Baricitinib in AD: Efficacy paired with consistent long-term results Next Article
Meaningful sleep improvement with IL-13 inhibition »
Table of Contents: EADV 2020
Featured articles
Late-Breaking News
Selective IL-23 blocker shows potential in psoriasis treatment
Promising results with nanobody treatment in psoriasis
Light at the end of the tunnel for chronic hand eczema
Epidermolysis bullosa: Novel wound treatment on the horizon
Efficacious non-steroidal topical for psoriasis
Oral JAK 1 inhibitor leads to fast itch relieve and remarkable skin clearance in AD
COVID-19: What Dermatologists Need to Know
Biologic psoriasis treatment and COVID-19 risk: Contradictory results
Much to be learned about COVID-19 and the skin
JAK Inhibitors – A Fascinating Novel Drug Class
JAK inhibitors in AA: re-establishing the immune privilege of hair follicles
JAK1 inhibition successful in hidradenitis suppurativa
Topical JAK inhibition: a novel treatment option for patients with mild-to-moderate AD
Urticaria – What’s new
Chronic inducible urticaria can require some detective work
Chronic spontaneous urticaria: hives, wheals & biomarkers
Ligelizumab for chronic spontaneous urticaria: a new star on the horizon
Infectious Diseases: Novel Developments
Bacterial resistance in skin infections – a challenging threat
Borreliosis: A multifaceted disease
Scabies – A global health challenge
Upcoming Treatments
Meaningful sleep improvement with IL-13 inhibition
Preventing foot odour with zinc oxide coated socks
Baricitinib in AD: Efficacy paired with consistent long-term results
Best of the Posters
Real-world data on brodalumab affirms efficacy and fast onset of action
Heightened risk for psychiatric comorbidities in hidradenitis suppurativa patients
Effects IL-13 blocker improves with longer treatment duration
Related Articles
December 17, 2020
Bacterial resistance in skin infections – a challenging threat
December 17, 2020
Chronic spontaneous urticaria: hives, wheals & biomarkers
December 17, 2020
Real-world data on brodalumab affirms efficacy and fast onset of action
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com